Del Sorbo Lorenzo, Goffi Alberto, Ranieri V Marco
Università di Torino, Dipartimento di Anestesiologia e Medicina degli Stati Critici, Ospedale S. Giovanni Battista-Molinette, 10126 Torino, Italy.
Presse Med. 2011 Dec;40(12 Pt 2):e569-83. doi: 10.1016/j.lpm.2011.05.028. Epub 2011 Nov 21.
Despite a very large body of investigations, no effective pharmacological therapies have been found to cure acute lung injury. Hence, supportive care with mechanical ventilation remains the cornerstone of treatment. However, several experimental and clinical studies showed that mechanical ventilation, especially at high tidal volumes and pressures, can cause or aggravate ALI. Therefore, current clinical recommendations are developed with the aim of avoiding ventilator-induced lung injury (VILI) by limiting tidal volume and distending ventilatory pressure according to the results of the ARDS Network trial, which has been to date the only intervention that has showed success in decreasing mortality in patients with ALI/ARDS. In the past decade, a very large body of investigations has determined significant achievements on the pathophysiological knowledge of VILI. Therefore, new perspectives, which will be reviewed in this article, have been defined in terms of the efficiency and efficacy of recognizing, monitoring and treating VILI, which will eventually lead to further significant improvement of outcome in patients with ARDS.
尽管进行了大量研究,但尚未发现有效的药物疗法可治愈急性肺损伤。因此,机械通气支持治疗仍然是治疗的基石。然而,多项实验和临床研究表明,机械通气,尤其是高潮气量和高压力通气,可导致或加重急性肺损伤。因此,根据急性呼吸窘迫综合征(ARDS)网络试验的结果,目前制定的临床建议旨在通过限制潮气量和通气压力来避免呼吸机诱导的肺损伤(VILI),该试验是迄今为止唯一一项在降低急性肺损伤/急性呼吸窘迫综合征患者死亡率方面取得成功的干预措施。在过去十年中,大量研究在呼吸机诱导的肺损伤的病理生理知识方面取得了重大成果。因此,本文将对这些新观点进行综述,这些新观点在识别、监测和治疗呼吸机诱导的肺损伤的效率和效果方面已经得到明确,最终将进一步显著改善急性呼吸窘迫综合征患者的预后。